Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Wajeeh Khan

BIZARRE: Should you chase the rally in hims hers stock today - What They Never Told You

Hims & Hers (HIMS) shares rallied another 6% in premarket today after Eli Lilly (LLY) warned of health risks from impurity it discovered in the compounded version of its weight-loss drug.

This helped HIMS push higher as the company just announced a truce and partnership with Ozempic- and Wegovy-maker Novo Nordisk (NVO), reinforcing its transition from a high-risk “gray market” pharmacy to a legitimate, sanctioned distribution partner for Big Pharma. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.